Published in J Med Screen on January 01, 2010
The benefits and harms of breast cancer screening: an independent review. Br J Cancer (2013) 3.43
Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br J Cancer (2011) 2.28
Possible net harms of breast cancer screening: updated modelling of Forrest report. BMJ (2011) 2.22
Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time. Breast Cancer Res (2013) 2.11
Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev (2011) 1.77
Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods. BMJ (2015) 1.61
Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis. J Natl Cancer Inst (2015) 1.56
Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program. Breast Cancer Res Treat (2012) 1.47
Registry-based study of trends in breast cancer screening mammography before and after the 2009 U.S. Preventive Services Task Force recommendations. Radiology (2013) 1.39
Women's responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study. BMJ Open (2013) 1.27
Balancing harms and benefits of service mammography screening programs: a cohort study. Breast Cancer Res (2012) 1.19
The breast screening programme and misinforming the public. J R Soc Med (2011) 1.09
Prevalence of abnormalities influences cytologists' error rates in screening for cervical cancer. Arch Pathol Lab Med (2011) 1.02
A survey study of women's responses to information about overdiagnosis in breast cancer screening in Britain. Br J Cancer (2014) 0.98
Beyond the mammography debate: a moderate perspective. Curr Oncol (2015) 0.97
Economic analyses of breast cancer control in low- and middle-income countries: a systematic review. Syst Rev (2013) 0.92
The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS. Br J Cancer (2012) 0.91
Effect of insurance status on the stage of breast and colorectal cancers in a safety-net hospital. J Oncol Pract (2012) 0.89
Nonpalpable breast carcinomas: long-term evaluation of 1,258 cases. Oncologist (2010) 0.88
Advantages and Disadvantages of Mammography Screening. Breast Care (Basel) (2011) 0.87
Screening mammography & breast cancer mortality: meta-analysis of quasi-experimental studies. PLoS One (2014) 0.87
Overdiagnosis: epidemiologic concepts and estimation. Epidemiol Health (2015) 0.84
Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom. Breast Cancer Res (2012) 0.82
Framing overdiagnosis in breast screening: a qualitative study with Australian experts. BMC Cancer (2015) 0.81
Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study. Br J Cancer (2016) 0.81
Breast screening: why estimates differ by a factor of 20-25. J Med Screen (2010) 0.79
Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland. Br J Cancer (2014) 0.79
The dynamic optical breast imaging in the preoperative workflow of women with suspicious or malignant breast lesions: development of a new comprehensive score. ISRN Oncol (2012) 0.77
Implications of Overdiagnosis: Impact on Screening Mammography Practices. Popul Health Manag (2015) 0.77
Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK. Breast (2015) 0.77
Mammography screening in three Finnish residential areas: comprehensive population-based study of breast cancer incidence and incidence-based mortality 1976-2009. Br J Cancer (2015) 0.77
A pragmatic assessment of the relative efficiency of outreach chlamydia screening events conducted in non-clinical settings. BMC Public Health (2012) 0.76
An ongoing case-control study to evaluate the NHS breast screening programme. BMC Cancer (2013) 0.76
Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening Programme. J Med Screen (2016) 0.76
Breast screening review--a radiologist's perspective. Br J Radiol (2012) 0.76
Flexible sigmoidoscopy--valuable in colorectal cancer. Nat Rev Clin Oncol (2010) 0.75
Misplaced criticism of breast screening research. J R Soc Med (2012) 0.75
Letter in response to "Cherry-picking of evidence fails to accurately show extent of overdiagnosis: Mammographic screening harms understated". J Med Radiat Sci (2013) 0.75
Cherry-picking of evidence fails to accurately show extent of overdiagnosis: Mammographic screening harms understated. J Med Radiat Sci (2013) 0.75
Radiation risk of breast screening in England with digital mammography. Br J Radiol (2016) 0.75
Absolute numbers of lives saved and overdiagnosis in breast cancer screening. J Med Screen (2010) 0.75
More breast screening data. Rev Obstet Gynecol (2010) 0.75
Information on 'Overdiagnosis' in Breast Cancer Screening on Prominent United Kingdom- and Australia-Oriented Health Websites. PLoS One (2016) 0.75
The transplant patient and transplant medicine in family practice. J Family Med Prim Care (2015) 0.75
Personalised informed choice on evidence and controversy on mammography screening: study protocol for a randomized controlled trial. BMC Cancer (2017) 0.75
Mammographic screening for breast cancer: A review. J Med Radiat Sci (2013) 0.75
A meta-analysis of mammographic screening with and without clinical breast examination. Cancer Sci (2015) 0.75
Benefit-to-harm ratio of the Danish breast cancer screening programme. Int J Cancer (2017) 0.75
Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet (2002) 13.16
Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2002) 12.65
Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ (2009) 8.31
Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ (2006) 5.82
Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ (2004) 4.94
Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am (1992) 4.34
Breast screening: the facts--or maybe not. BMJ (2009) 3.21
The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am (2004) 3.06
Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res (2005) 2.67
Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev (2006) 2.53
Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program. Breast J (2006) 2.24
Complexities in the estimation of overdiagnosis in breast cancer screening. Br J Cancer (2008) 1.90
Screening for breast cancer in England: past and future. J Med Screen (2006) 1.88
Breast screening saves lives. BMJ (2009) 1.58
Screening for breast cancer: the UK scene. The 69th Mackenzie Davidson memorial lecture. Br J Radiol (1989) 1.58
Some current issues in breast cancer screening. J Med Screen (2005) 1.57
Number needed to screen: lives saved over 20 years of follow-up in mammographic screening. J Med Screen (2004) 1.31
Screening for breast cancer in England: a review. Curr Opin Obstet Gynecol (2008) 1.09
Populist instead of professional. J Med Screen (2000) 1.01
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin (2008) 12.90
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin (2007) 12.19
American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin (2010) 6.45
American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin (2002) 5.56
Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet (2003) 5.40
Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology (2011) 5.17
Effect of population-based screening on breast cancer mortality. Lancet (2011) 5.06
Worldwide variations in colorectal cancer. CA Cancer J Clin (2009) 4.71
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology (2006) 4.57
Supplemental oxygen impairs detection of hypoventilation by pulse oximetry. Chest (2004) 3.55
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin (2006) 3.21
American Cancer Society lung cancer screening guidelines. CA Cancer J Clin (2013) 3.16
The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am (2004) 3.06
A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med (2005) 3.01
Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation (2004) 2.91
The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer (2002) 2.85
The efficacy and safety of pain management before and after implementation of hospital-wide pain management standards: is patient safety compromised by treatment based solely on numerical pain ratings? Anesth Analg (2005) 2.83
Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc (2007) 2.82
American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin (2007) 2.81
Counterpoint: Overdiagnosis in breast cancer screening. J Am Coll Radiol (2014) 2.75
Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res (2005) 2.67
International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol (2012) 2.45
Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer (2008) 2.41
Insights from the breast cancer screening trials: how screening affects the natural history of breast cancer and implications for evaluating service screening programs. Breast J (2014) 2.37
Sequential design approaches for bioequivalence studies with crossover designs. Pharm Stat (2008) 2.33
Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer (2008) 2.28
Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med (2010) 2.17
Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers. Hum Pathol (2013) 2.09
Identifying minimally acceptable interpretive performance criteria for screening mammography. Radiology (2010) 2.06
Correlates of underutilization of colorectal cancer screening among U.S. adults, age 50 years and older. Prev Med (2003) 2.05
Molecular and structural characterization of barley vernalization genes. Plant Mol Biol (2005) 2.01
Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer (2008) 1.90
Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2006) 1.89
Modelling the cumulative risk of a false-positive screening test. Stat Methods Med Res (2010) 1.87
Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable. Cancer (2002) 1.87
Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J (2006) 1.85
Predicting the risk of a false-positive test for women following a mammography screening programme. J Med Screen (2007) 1.83
Influence of annual interpretive volume on screening mammography performance in the United States. Radiology (2011) 1.81
Colorectal cancer screening barriers and facilitators in older persons. Prev Med (2009) 1.73
A perspective from countries using organized screening programs. Cancer (2004) 1.72
Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival. Am J Epidemiol (2008) 1.71
Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma. Cancer (2004) 1.70
Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening. Cancer Epidemiol Biomarkers Prev (2010) 1.69
Structural, functional, and phylogenetic characterization of a large CBF gene family in barley. Plant Mol Biol (2005) 1.63
Validation of the VRN-H2/VRN-H1 epistatic model in barley reveals that intron length variation in VRN-H1 may account for a continuum of vernalization sensitivity. Mol Genet Genomics (2006) 1.63
Revised colorectal screening guidelines: joint effort of the American Cancer Society, U.S. Multisociety Task Force on Colorectal Cancer, and American College of Radiology. Radiology (2008) 1.60
Progression rates of colorectal cancer by Dukes' stage in a high-risk group: analysis of selective colorectal cancer screening. Cancer J (2004) 1.53
Colonoscopy surveillance after polypectomy and colorectal cancer resection. Am Fam Physician (2008) 1.52
Carcinoma ex pleomorphic adenoma: a comprehensive review of clinical, pathological and molecular data. Head Neck Pathol (2011) 1.52
Mammographic screening and "overdiagnosis". Radiology (2011) 1.48
Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers. CA Cancer J Clin (2003) 1.44
Breast cancer in limited-resource countries: early detection and access to care. Breast J (2006) 1.43
Time-dependent effects on survival in breast carcinoma: results of 20 years of follow-up from the Swedish Two-County Study. Cancer (2004) 1.42
Prevention and early detection clinical trials: opportunities for primary care providers and their patients. CA Cancer J Clin (2003) 1.41
A 3-year panel study of mental disorders among adolescents in Taiwan. Am J Psychiatry (2005) 1.40
[Mammography screening without overdiagnosis]. Ugeskr Laeger (2004) 1.38
Professional and economic factors affecting access to mammography: a crisis today, or tomorrow? Results from a national survey. Cancer (2005) 1.38
The influence of media reporting of the suicide of a celebrity on suicide rates: a population-based study. Int J Epidemiol (2007) 1.35
Breast cancer incidence after the introduction of mammography screening: what should be expected? Cancer (2006) 1.35
Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer. CA Cancer J Clin (2006) 1.33
Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resouce-limited West Africa. Clin Infect Dis (2009) 1.33
Mapping of barley homologs to genes that regulate low temperature tolerance in Arabidopsis. Theor Appl Genet (2005) 1.29
Mammography screening in the county of Fyn. November 1993-December 1999. APMIS Suppl (2003) 1.27
Survey of radiology residents: breast imaging training and attitudes. Radiology (2003) 1.26
Asthma outcomes: healthcare utilization and costs. J Allergy Clin Immunol (2012) 1.23
Hydrogen peroxide-induced oxidative stress in MC3T3-E1 cells: The effects of glutamate and protection by purines. Bone (2006) 1.21
A prospective surveillance model for rehabilitation for women with breast cancer. Cancer (2012) 1.21
Long-term prognosis of patients with biliary atresia: a 25 year summary. J Pediatr Gastroenterol Nutr (2006) 1.20
Overdiagnosis in screening mammography in Denmark: population based cohort study. BMJ (2013) 1.20
The future of research that promotes cancer screening. Cancer (2004) 1.18
The CBF1-dependent low temperature signalling pathway, regulon and increase in freeze tolerance are conserved in Populus spp. Plant Cell Environ (2006) 1.17
Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations. J Gen Intern Med (2010) 1.16
Do nonattenders in mammography screening programmes seek mammography elsewhere? Int J Cancer (2005) 1.15
Toward standardizing and reporting colorectal cancer screening indicators on an international level: The International Colorectal Cancer Screening Network. Int J Cancer (2011) 1.15
A comparison of the low temperature transcriptomes and CBF regulons of three plant species that differ in freezing tolerance: Solanum commersonii, Solanum tuberosum, and Arabidopsis thaliana. J Exp Bot (2011) 1.12
Women's patterns of participation in mammography screening in Denmark. Eur J Epidemiol (2006) 1.11
Validation for clinical use of a novel HIV-2 plasma RNA viral load assay using the Abbott m2000 platform. J Clin Virol (2012) 1.10
Genetic engineering of glycinebetaine synthesis in tomato protects seeds, plants, and flowers from chilling damage. Plant J (2004) 1.08
Early detection of breast cancer in countries with limited resources. Breast J (2003) 1.08
Permissive and repulsive cues and signalling pathways of axonal outgrowth and regeneration. Int Rev Cell Mol Biol (2008) 1.06
Mutator suppression and escape from replication error-induced extinction in yeast. PLoS Genet (2011) 1.05
American cancer society guideline for the early detection of cervical neoplasia and cancer. J Low Genit Tract Dis (2003) 1.04
The evolving role of MRI in the detection and evaluation of breast cancer. N Engl J Med (2007) 1.03
Promoting cancer screening: Learning from experience. Cancer (2004) 1.02
The quality of colonoscopy services--responsibilities of referring clinicians: a consensus statement of the Quality Assurance Task Group, National Colorectal Cancer Roundtable. J Gen Intern Med (2010) 1.02
Mammography activity in Norway 1983 to 2008. Acta Oncol (2011) 1.02
Socio-demographic determinants of participation in mammography screening. Int J Cancer (2008) 1.02
Radiologist agreement for mammographic recall by case difficulty and finding type. J Am Coll Radiol (2012) 1.01
Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening. Cancer (2012) 1.01
Epistatic effects of potassium channel variation on cardiac repolarization and atrial fibrillation risk. J Am Coll Cardiol (2012) 1.00
Use of a stress inducible promoter to drive ectopic AtCBF expression improves potato freezing tolerance while minimizing negative effects on tuber yield. Plant Biotechnol J (2007) 0.99
Prostate cancer screening 2010: updated recommendations from the American Cancer Society. J Natl Med Assoc (2010) 0.98
Measuring the modified early warning score and the Rothman index: advantages of utilizing the electronic medical record in an early warning system. J Hosp Med (2013) 0.97